Your browser doesn't support javascript.
loading
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state.
Echeverria, Gloria V; Ge, Zhongqi; Seth, Sahil; Zhang, Xiaomei; Jeter-Jones, Sabrina; Zhou, Xinhui; Cai, Shirong; Tu, Yizheng; McCoy, Aaron; Peoples, Michael; Sun, Yuting; Qiu, Huan; Chang, Qing; Bristow, Christopher; Carugo, Alessandro; Shao, Jiansu; Ma, Xiaoyan; Harris, Angela; Mundi, Prabhjot; Lau, Rosanna; Ramamoorthy, Vandhana; Wu, Yun; Alvarez, Mariano J; Califano, Andrea; Moulder, Stacy L; Symmans, William F; Marszalek, Joseph R; Heffernan, Timothy P; Chang, Jeffrey T; Piwnica-Worms, Helen.
Afiliação
  • Echeverria GV; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ge Z; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Seth S; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhang X; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Jeter-Jones S; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhou X; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Cai S; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Tu Y; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • McCoy A; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Peoples M; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sun Y; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Qiu H; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Chang Q; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Bristow C; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Carugo A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Shao J; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ma X; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Harris A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Mundi P; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lau R; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ramamoorthy V; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wu Y; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Alvarez MJ; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Califano A; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Moulder SL; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Symmans WF; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Marszalek JR; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Heffernan TP; Center for Co-Clinical Trials Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Chang JT; Department of Systems Biology, Columbia University Medical Center, New York, NY 10032, USA.
  • Piwnica-Worms H; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sci Transl Med ; 11(488)2019 04 17.
Article em En | MEDLINE | ID: mdl-30996079
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos